ID   TH4-7-5
AC   CVCL_B7RA
DR   Wikidata; Q112930468
RX   Patent=DE3940527C2;
RX   Patent=WO1990015150A1;
RX   PubMed=1373627;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-861.
CC   Virology: In vitro persistently infected by HIV-1. Produces substantial amounts of Nef (PubMed=1373627).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7R9 ! 85HG-66
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
RX   Patent=DE3940527C2;
RA   Erfle V., Mellert W.;
RT   "Human cell line TH4-7-5, its use and method for producing a protein
RT   product of an HIV regulatory gene.";
RL   Patent number DE3940527C2, 07-Aug-1997.
//
RX   Patent=WO1990015150A1;
RA   Erfle V., Mellert W.;
RT   "Process for obtaining a regulation protein (nef) for HIV-1 using the
RT   human cell line TH4-7-5.";
RL   Patent number WO1990015150A1, 13-Dec-1990.
//
RX   PubMed=1373627; DOI=10.1097/00002030-199203000-00004;
RA   Brack-Werner R., Kleinschmidt A., Ludvigsen A., Mellert W.,
RA   Neumann M., Herrmann R., Khim M.C.L., Burny A., Muller-Lantzsch N.,
RA   Stavrou D., Erfle V.;
RT   "Infection of human brain cells by HIV-1: restricted virus production
RT   in chronically infected human glial cell lines.";
RL   AIDS 6:273-285(1992).
//